PF-ILD associated with respiratory failure is a suspected infectious disease in the area of respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multiple systemic stresses. Early identification and standardized diagnosis are critical to improving prognosis.
Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment and management of PF-ILD associated with respiratory failure requires individualized development of treatment plans, usually including multidimensional management of drug therapy, rehabilitation, regular follow-up, etc.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine diseases have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted for changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of respiratory failure associated with PF-ILD.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.